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Abstract
Background: The b-secretase, b-site amyloid precursor protein cleaving enzyme 1 (BACE1), is a prime therapeutic
target for lowering cerebral b-amyloid (Ab) levels in Alzheimer’s disease (AD). Clinical development of BACE1
inhibitors is being intensely pursued. However, little is known about the physiological functions of BACE1, and the
possibility exists that BACE1 inhibition may cause mechanism-based side effects. Indeed, BACE1
-/- mice exhibit a
complex neurological phenotype. Interestingly, BACE1 co-localizes with presynaptic neuronal markers, indicating a
role in axons and/or terminals. Moreover, recent studies suggest axon guidance molecules are potential BACE1
substrates. Here, we used a genetic approach to investigate the function of BACE1 in axon guidance of olfactory
sensory neurons (OSNs), a well-studied model of axon targeting in vivo.
Results: We bred BACE1
-/- mice with gene-targeted mice in which GFP is expressed from the loci of two odorant-
receptors (ORs), MOR23 and M72, and olfactory marker protein (OMP) to produce offspring that were heterozygous
for MOR23-GFP, M72-GFP, or OMP-GFP and were either BACE1
+/+ or BACE1
-/-. BACE1
-/- mice had olfactory bulbs
(OBs) that were smaller and weighed less than OBs of BACE1
+/+ mice. In wild-type mice, BACE1 was present in
OSN axon terminals in OB glomeruli. In whole-mount preparations and tissue sections, many OB glomeruli from
OMP-GFP; BACE1
-/- mice were malformed compared to wild-type glomeruli. MOR23-GFP; BACE1
-/- mice had an
irregular MOR23 glomerulus that was innervated by randomly oriented, poorly fasciculated OSN axons compared
to BACE1
+/+ mice. Most importantly, M72-GFP; BACE1
-/- mice exhibited M72 OSN axons that were mis-targeted to
ectopic glomeruli, indicating impaired axon guidance in BACE1
-/- mice.
Conclusions: Our results demonstrate that BACE1 is required for the accurate targeting of OSN axons and the
proper formation of glomeruli in the OB, suggesting a role for BACE1 in axon guidance. OSNs continually undergo
regeneration and hence require ongoing axon guidance. Neurogenesis and the regeneration of neurons and axons
occur in other adult populations of peripheral and central neurons that also require axon guidance throughout life.
Therefore, BACE1 inhibitors under development for the treatment of AD may potentially cause axon targeting
defects in these neuronal populations as well.
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Proteolytic processing of the amyloid precursor protein
(APP) by the b-a n dg-secretases produces the Ab pep-
tide that forms amyloid plaques and plays a central role
in AD pathogenesis. The b-secretase has been identified
as the transmembrane aspartic protease BACE1 [1-5].
BACE1 cuts APP to produce a membrane-bound
C-terminal fragment C99 that is further processed by
g-secretase to generate Ab. BACE1 gene deletion in
mice abrogates Ab generation. Thus, BACE1 is consid-
ered a prime therapeutic target for AD.
Although BACE1
-/- m i c ea r ev i a b l ea n df e r t i l e[ 6 , 7 ] ,
they exhibit hippocampus-dependent memory deficits
[8-10] and display abnormal EEGs and seizures [11,12].
Moreover, BACE1
-/- mice have hypomyelination [13,14],
and additional BACE1
-/- phenotypes may exist. The
molecular mechanisms that underlie the complex phe-
notypes of BACE1
-/- mice are not fully understood.
Taken together, data suggest that therapeutic BACE1
inhibition may produce mechanism-based side-effects,
thus underscoring the importance of fully understanding
BACE1 physiological functions.
Deficient processing of specific BACE1 substrates
appears to be the cause of certain BACE1
-/- phenotypes.
For example, BACE1
-/- hypomyelination results from
reduced BACE1 cleavage of type III neuregulin-1 [13,14]
and deficient BACE1 processing of b2s o d i u mc h a n n e l
subunit [12,15,16] may cause seizures. A growing list of
BACE1 substrates exists [17] and more will likely be dis-
covered. A recent unbiased proteomics screen for novel
BACE1 substrates suggested that members of different
axon guidance molecule families were processed by
BACE1 [18]. BACE1 levels are highest in neurons [1-3],
especially in presynaptic terminals [19]. These results sug-
gest that BACE1 has an important function in neurons,
potentially in the axonal or terminal compartment. Intri-
guingly, the highest levels of BACE1 in the OB are in OSN
axon terminals in glomeruli [20], suggesting a role for
BACE1 there.
T h ea x o n a lp r o j e c t i o n sf r o mO S N st ot h eO Bf o r ma
topographic map through axon guidance processes that
have been extensively studied in rodents and that are
amenable to investigation using gene targeted mice [21].
The olfactory epithelium (OE) of mammals consists of
~10
7-10
9 OSNs that each project a single axon to the
OB, the first relay of the olfactory system. The mamma-
lian genome encodes ~1000 different odorant receptor
(OR) genes [22]. Each OSN appears to express only one
OR gene [23,24]. Therefore, depolarization of a given
OSN identifies the specific OR that has been activated.
In addition, OSNs expressing a given OR gene are dis-
tributed randomly within distinct expression zones of
the OE [23,24]. This essentially random arrangement of
OSNs creates a problem for the brain to determine
which OSN has been stimulated in the OE for identify-
ing the specific OR that has been activated. To solve
this problem, axons of OSNs expressing a given OR
gene converge onto ~2 glomeruli in spatially defined
regions of the OB, thus establishing a glomerular map
that represents OR activation and hence odor quality
[25-27]. Each OB has ~1000 distinct populations of
axons that coalesce into ~2000 glomeruli creating a for-
midable axon guidance problem both during development
and in the adult, since OSNs continually regenerate and
project new axons to glomeruli throughout life.
Here, we have taken advantage of the well-studied OSN
axon targeting to the OB and the availability of OR gene
targeted mice to investigate the role of BACE1 in axon
guidance. To do so, we bred BACE1
-/- mice with gene-tar-
geted mice in which GFP is expressed from the loci of two
ORs, MOR23 and M72, and OMP. We observed that
many BACE1
-/- glomeruli had abnormal morphologies as
compared to BACE1
+/+ glomeruli. Most notably, M72-
GFP; BACE1
-/- mice exhibited mis-targeting of M72 OSN
axons to multiple ectopic glomeruli, in contrast to a single
glomerulus per convergence site for BACE1
+/+ M72 OSN
axons. Together, these results suggest that BACE1 partici-
pates in axon guidance, at least in OSNs, and they imply
the possibility that therapeutic inhibition of BACE1 for
AD may result in axon mis-targeting in humans.
Results
BACE1
-/- OB glomeruli have abnormal morphology
We noticed during routine dissections that the OBs of
BACE1
-/- mice appeared smaller than those of BACE1
+/+
mice. To quantify this, we weighted OBs and brains from
~2-5 month-old BACE1
-/- and BACE1
+/+ mice and nor-
malized OB weight to total brain weight for each genotype
to exclude any effects of growth retardation [28]. We
found that the normalized weights of BACE1
-/- OBs were
88.0 ± 2.74 (SEM)%, compared to 100 ± 3.17 (SEM)% for
BACE1
+/+ OBs (p = 0.00856). Although this weight differ-
ence was small, it was statistically significant and it could
not be attributed to decreased total brain weight for
BACE1
-/- mice, and therefore it suggested that BACE1
deficiency had a selective effect on OBs.
Targeted gene deletions and manipulations (e.g., naris
occlusion) that reduce peripheral olfactory input decrease
OB size [29-33]. Therefore, the reduced size and weight
of BACE1
-/- OBs strongly suggested that OSN axon gui-
dance was perturbed, particularly since BACE1 is not
abundant in the OB, except in OSN axon terminals [20].
Because axon guidance molecules were reported to be
BACE1 substrates [18], we investigated whether the
BACE1
-/- OB phenotype was related to impaired OSN
axon formation or guidance. To initially test this, we
bred BACE1
-/- mice with gene-targeted mice in which
GFP is expressed from the locus of OMP (OMP-GFP
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were either BACE1
-/- or BACE1
+/+. These mice displayed
GFP labeling in all OSN axons and their terminals.
Therefore, the entire olfactory nerve layer and all glomer-
uli of the OBs of these mice were labeled with GFP.
Whole-mount laser scanning confocal microscopy of
OMP-GFP; BACE1
-/- and OMP-GFP; BACE1
+/+ OBs con-
firmed the smaller size of BACE1
-/- OBs (compare Figures
1A and 1D). When viewed at higher magnification, indivi-
dual OMP-GFP; BACE1
-/- OSN axon bundles and glomer-
uli exhibited diminished visual clarity as compared to
those of OMP-GFP; BACE1
+/+ OBs (compare Figures 1B
and 1E), suggesting that the anatomical organization or
structure of BACE1
-/- OSN axons and glomeruli was per-
turbed. Abnormal morphologies of OMP-GFP; BACE1
-/-
glomeruli were particularly evident in individual confocal
optical sections (compare Figures 1C and 1F), suggesting
that BACE1 deficiency caused glomerular malformation.
We next prepared coronal sections and performed laser
scanning confocal microscopy of OMP-GFP; BACE1
-/-
and OMP-GFP; BACE1
+/+ OBs to investigate the mor-
phology of BACE1
-/- glomeruli in greater detail (Figure 2).
GFP signal in OMP-GFP; BACE1
-/- OB sections revealed
that many BACE1
-/- glomeruli were markedly deformed
(Figure 2F), as compared to the typical spherical/elliptical
shape of BACE1
+/+ glomeruli (Figure 2B). A significant
amount of co-localization of the signals for GFP and anti-
BACE1 antibody immunostaining demonstrated the pre-
sence of BACE1 in OSN axon terminals of BACE1
+/+ OB
glomeruli (Figure 2A-D). BACE1 immunofluorescence sig-
nal was absent from OMP-GFP; BACE1
-/- OB sections, as
expected (Figure 2E). Taken together, these data suggested
that genetic abrogation of BACE1 expression in OSN
axons resulted in a higher frequency of malformed OB
glomeruli.
OSNs expressing specific ORs exhibit axon guidance
defects in BACE1
-/- OBs
One interpretation of our results with OMP-GFP;
BACE1
-/- mice was that OSN axon guidance was
impaired by BACE1 deficiency. To investigate whether
BACE1 gene deletion perturbed the axonal projections of
OSNs that express a specific OR, we employed gene-tar-
geted mice in which GFP is expressed from the locus of
the OR called MOR23 (MOR23-GFP mice) [35]. These
mice display GFP labeling in MOR23 OR-expressing
OSN axons, which project to only one topographically
fixed glomerulus on each side of an individual OB. We
bred BACE1
-/- mice with MOR23-GFP mice to produce
heterozygous MOR23-GFP mice that were either
BACE1
-/- or BACE1
+/+ and prepared coronal OB sections
for immunofluorescence confocal microscopy (Figure 3).
Figure 1 Reduced clarity of OSN axon bundles and glomeruli in BACE1
-/- OBs. Whole-mount preparations of OMP-GFP; BACE1
+/+ (A, B, C)
and OMP-GFP; BACE1
-/- (D, E, F) OBs from 30 day-old mice were imaged for GFP fluorescence by laser scanning confocal microscopy. Z-stacks of
optical sections were collected and collapsed into single images (A, B, D, E). Higher magnification images (B, E) of boxed regions in (A, D) show
decreased clarity of OSN axons and reduced definition of glomeruli in the BACE1
-/- OB as compared to BACE1
+/+. Abnormal morphologies of
BACE1
-/- relative to BACE1
+/+ glomeruli are particularly evident in individual optical sections taken at a depth of ~110 μm from the dorsal
surfaces of OBs (C, F). Note that the BACE1
-/- OB appears smaller in overall size relative to BACE1
+/+ (compare D to A). Images were taken of the
dorsal OB surfaces and are shown with the anterior tips of the OBs at the top.
Rajapaksha et al. Molecular Neurodegeneration 2011, 6:88
http://www.molecularneurodegeneration.com/content/6/1/88
Page 3 of 9Figure 2 Malformation of BACE1
-/- OB glomeruli. Coronal sections of OBs from 60 day-old OMP-GFP; BACE1
+/+ (A-D) and OMP-GFP; BACE1
-/-
(E-H) mice were immunostained with anti-BACE1 antibody and imaged for BACE1 (red; A, E), GFP (green; B, F), and DAPI for periglomerular cell
nuclei (blue; C, G) by laser scanning confocal microscopy. Three-color image merges are shown in (D, H). Robust GFP fluorescence is observed in
OSN axons and terminals in glomeruli (B, F). Note significant BACE1 co-localization with GFP in OSN terminals in BACE1
+/+ glomeruli (D).
Importantly, abrogation of BACE1 expression results in markedly deformed BACE1
-/- glomeruli (F, H) as compared to BACE1
+/+ (B, D). Scale bar in
(H) = 100 μm.
Figure 3 Atypical OSN axon innervation of MOR23 glomerulus in BACE1
-/- OBs. Coronal sections of OBs from 60 day-old MOR23-GFP;
BACE1
+/+ (A-D) and MOR23-GFP; BACE1
-/- (E-H) mice were immunostained with anti-BACE1 antibody and imaged for BACE1 (red; A, E), GFP
(green; B, F), and DAPI for periglomerular cell nuclei (blue; C, G) by laser scanning confocal microscopy. Three-color image merges are shown in
(D, H). Robust GFP fluorescence is observed in OSN axons and terminals in MOR23 glomeruli (B, F). Note that largely individual BACE1
-/- OSN
axons enter the MOR23 glomerulus from multiple directions and orientations (F, H), while most BACE1
+/+ OSN axons penetrate the MOR23
glomerulus as a bundle perpendicular to the glomerular layer (B, D), suggesting that BACE1 deficiency results in abnormal glomerular
innervation. Scale bar in (H) = 100 μm.
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-/- OB sections revealed that the
MOR23 glomerulus was irregular compared to wild-type.
In contrast to the BACE1
+/+ MOR23 glomerulus in
which OSN axons were organized mainly as a bundle
that entered perpendicular to the glomerular layer,
BACE1
-/- MOR23 OSN axons innervated the glomerulus
mostly as individual axons at oblique angles from multi-
ple directions (compare Figure 3F to 3B). As with OMP-
GFP; BACE1
+/+ OB sections, GFP signal in BACE1
+/+
MOR23 axons co-localized well with anti-BACE1 immu-
nostaining (Figure 3A-D). The randomly oriented, poorly
fasciculated BACE1
-/- MOR23 OSN axons implied that
BACE1 deficiency affected processes related to OSN
axon guidance.
To determine whether BACE1 gene deletion could
cause axon guidance defects in OSNs expressing a dif-
ferent OR, we used gene-targeted mice in which GFP is
expressed from the locus of the OR called M72 (M72-
GFP mice) [34]. We bred M72-GFP mice to BACE1
-/-
mice to produce heterozygous M72-GFP mice that were
either BACE1
-/- or BACE1
+/+ a n dt h e ni m a g e dt h e i r
OBs by whole-mount confocal microscopy as before
(Figure 4). The M72-GFP mice had OSN axons that tar-
geted a major glomerulus, however all the BACE1
-/-
mice also exhibited a subset of mis-targeted M72 OSN
axons that innervated one or more ectopic sites in the
OB that were near but not located within the M72 glo-
merulus (Figure 4A-D). As expected, all the M72-GFP;
BACE1
+/+ mice displayed only the single M72 glomeru-
lus with no ectopic sites innervated (Figure 4E, F). Thus,
the OSN axon guidance defect caused by BACE1 defi-
ciency was relatively more severe for M72 than MOR23.
To investigate the M72 OSN axon targeting defect of
BACE1
-/- mice in greater detail, we prepared coronal
OB sections from M72-GFP; BACE1
-/- and M72-GFP;
BACE1
+/+ mice and performed immunofluorescence
confocal microscopy as above (Figure 5). As expected,
M72 BACE1
+/+ OSN axons innervated a single M72 glo-
merulus (Figure 5B, D). Confirming our whole-mount
r e s u l t s ,w eo b s e r v e dt h a tm o s tB A C E 1
-/- M72 OSN
axons targeted a major glomerulus (Figure 5F, H). How-
ever, also consistent with the whole-mount data, a sub-
set of BACE1
-/- M72 OSN axons displayed mis-targeting
to ectopic glomeruli that were nearby but distinct from
the main M72 glomerulus (Figure 5F, H). Although the
OR specificities of the ectopic glomeruli have yet to be
determined, these results demonstrate that BACE1 parti-
cipates in OSN axon guidance and that BACE1 defi-
ciency increases the error rate of OSN axon targeting, at
least for M72 expressing OSNs.
Discussion
Using a genetic approach, we determined the effects of
BACE1 deficiency on OSN axon guidance using mice
that have GFP expression coupled to the expression of a
universally expressed OSN protein, OMP, and two dif-
ferent ORs, MOR23 and M72. We found that BACE1
plays a role in maintaining the accuracy of OSN axon
targeting to specific OR glomeruli in the OB, and is also
required for the normal morphological formation of OB
glomeruli, at least for some OR specificities. BACE1 is
present in OSN axon terminals in glomeruli, at the pre-
cise location where it can exert influence over axon gui-
dance processes. In addition, BACE1
-/- OBs are smaller
and weigh less than wild-type OBs. Taken together,
these results strongly suggest that BACE1 has a function
in certain aspects of axon guidance.
BACE1 has a large and growing list of known sub-
strates [17], and it is likely that many others exist that
have yet to be discovered. BACE1
-/- mice have a complex
phenotype that is presumably derived from the summed
effects of deficient processing of the entire complement
of BACE1 substrates expressed throughout the body.
Since neurons express the highest levels of BACE1 [1-3],
we have focused on the neuronal substrates of BACE1. A
recent unbiased proteomics screen uncovered a large
number of novel putative BACE1 substrates [18], but
most have yet to pass in vivo validation in BACE1
-/-
mice. Intriguingly, a number of these putative BACE1
substrates are members of families of proteins that parti-
cipate in axon guidance, including semaphorins, round-
about homologs, ephrins and Eph receptors, netrin
receptor, NCAMs, protocadherins, and syndecans. An
important first step in understanding the molecular basis
of the role of BACE1 in axon guidance will be to deter-
mine which if any of these putative BACE1 substrates are
processed by BACE1 in vivo and which are responsible
for impaired OSN axon targeting in BACE1
-/- mice. In
addition, it will be of interest to determine the functional
consequences of BACE1 deficiency on olfactory
perception.
Conclusions
We conclude from our study that BACE1 has a role in
axon guidance, at least in targeting OSN axons to glo-
meruli of the OB. It is currently unknown whether
BACE1 participates in the guidance of axons in other
neural systems of the body. Since several putative BACE1
substrates are widely expressed in both peripheral and
central neurons, as is BACE1, one may speculate that
BACE1 could influence axon guidance in multiple neural
systems. In BACE1
-/- mice, compensation from other
proteases may occur during development to rescue most
axon targeting defects. Once stable connections are
made, axon guidance, and hence a role for BACE1, may
no longer be required. However, OSNs continually regen-
erate and thus require axon guidance, and BACE1,
throughout life. Importantly, the axons of many adult
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together with adult CNS neural progenitor cell popula-
tions, also require ongoing axon guidance. Hence, the
f u n c t i o no fB A C E 1i na x o ng u i d a n c em a yb er e q u i r e d
well into old age, precisely when human beings are at
risk for AD. If BACE1 participates in the axon guidance
of certain adult neuron populations, as our study sug-
gests, then the therapeutic inhibition of BACE1 for AD
may produce untoward side effects in those neurons. It
remains to be seen whether this concern is justified, how-
ever our findings indicate that current and future clinical
trials with BACE1 inhibitor drugs should incorporate
tests for symptoms that might indicate dysfunction in
neurogenic and/or axon regenerating neuronal systems.
Methods
Mice
BACE1
-/- mice [36] were purchased from Jackson
Laboratory (Bar Harbor, ME) (stock number 004714).
OMP-GFP [34], MOR23-GFP [35], and M72-GFP [34]
mice have been reported previously. OMP-GFP is a gene-
targeted mouse strain in which GFP is expressed from
Figure 4 M72 OSN axons terminate at ectopic sites in BACE1
-/- OBs. Whole-mount preparations of M72-GFP; BACE1
-/- (A-D) and M72-GFP;
BACE1
+/+ (E, F) OBs from 30 day-old mice were imaged for GFP fluorescence by laser scanning confocal microscopy. Z-stacks were collected
and then collapsed into single images. Shown are 10× images of left (L) and right (R) OBs from two M72-GFP; BACE1
-/- mice (KO#1, KO#2) and
one M72-GFP; BACE1
+/+ mouse (WT). M72 OSN axons from all BACE1
+/+ and BACE1
-/- mice innervate a major glomerulus. However, subsets of
BACE1
-/- M72 OSN axons also target ectopic sites in the OBs that are near, but not within, the M72 glomerulus (arrows in A, C, and D). Although
ectopic sites are not prominent in KO#1-ROB, the pattern of axon targeting to the M72 glomerulus appears abnormal, with two sites of
innervation (B). In addition, OSN axons of KO#2-LOB appear to innervate two major glomeruli instead of one (C). Note that pigment cells
obscure some regions of OSN axons in the WT-LOB image (E). Dorsal OB surfaces are shown with the anterior OB at the top of each image.
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referred to as MOR23-IRES-tauGFP) is a gene-targeted
mouse strain harboring an IRES-tau-GFP fusion gene
inserted 3’ of the MOR23 OR gene coding region. M72-
GFP (originally referred to as M72-IRES-tauGFP) is a
gene-targeted mouse strain harboring an IRES-tau-
enhanced green fluorescent protein (EGFP) fusion gene
inserted 3’ of the OR 160 (M72) gene coding region.
BACE1
-/- mice were bred to each of the above strains to
produce heterozygous OMP-GFP, MOR23-GFP, or M72-
GFP mice that were either BACE1
+/+ or BACE1
-/-. Breed-
ing colonies of mice were maintained in the Northwes-
tern University Center for Comparative Medicine animal
facilities. All animal procedures were in strict accordance
with the NIH Guide for the Care and Use of Laboratory
Animals and were approved by the Northwestern Univer-
sity Animal Care and Use Committee.
Antibodies and reagents
Anti-BACE1 rabbit monoclonal antibody (D10E5) was
purchased from Cell Signaling (Boston, MA). Alexa
Fluor 568-conjugated donkey anti-rabbit secondary
antibody was purchased from Invitrogen (Carlsbad,
CA). DAPI was purchased from Invitrogen (Carlsbad,
CA).
Whole-mount confocal microscopy
Mice were euthanized with carbon dioxide gas and the
skull removed to expose the dorsal surfaces of the olfac-
tory bulbs. The dissected head was stabilized dorsal
side-up in a dish with Phosphate Buffered Saline.
Unfixed whole-mount olfactory bulbs were imaged for
GFP fluorescence on a laser scanning confocal micro-
scope (Carl Zeiss LSM5 Pascal, Germany) with a 488
nm laser line and z-stack images were collected. Images
were obtained within 30 minutes after euthanasia.
Immunofluorescence confocal microscopy
Mice were deeply anesthetized with intraperitoneal
injection of ketamine (200 mg/kg)/xylazine (25 mg/kg)
and then transcardially perfused with 10% formalin in
Phosphate Buffered Saline (PBS) before removal of
olfactory bulbs. Both olfactory bulbs and the attached
hemibrains were fixed in 10% formalin in PBS for 24 h
and then cryopreserved in subsequent 24-hour cycles of
15%, 20% and 30% (w/v) sucrose, over a 72-hour period.
30 μm coronal sections were cut from cryopreserved
olfactory bulbs on a freezing sliding microtome and col-
lected in 0.1 M TBS. Free-floating OB sections were
blocked in 5% donkey serum for 90 minutes on a rock-
ing platform. Sections were incubated in 1:250 dilution
Figure 5 M72 OSN axons are mis-targeted to ectopic glomeruli in BACE1
-/- OBs. Coronal sections of OBs from 60 day-old M72-GFP; BACE1
+/+ (A-D) and M72-GFP; BACE1
-/- (E-H) mice were immunostained with anti-BACE1 antibody and imaged for BACE1 (red; A, E), GFP (green; B, F),
and DAPI for periglomerular cell nuclei (blue; C, G) by laser scanning confocal microscopy. Three-color image merges are shown in (D, H). M72
OSN axons innervate a single glomerulus in the BACE1
+/+ OB (B, D). In contrast, BACE1
-/- M72 OSN axons target a major glomerulus (upper) and
a minor glomerulus (lower) that are separated by ~3-4 intervening glomeruli (F, H). Note the presence of a single mis-targeted axon that wraps
around the glomerulus adjacent to the major BACE1
-/- M72 glomerulus (F, H). These results strongly suggest that BACE1 deficiency causes axon
guidance defects, at least for M72 expressing OSNs. Scale bar in (H) = 100 μm.
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ing, Boston, MA) in TBS + 0.25% Triton-X 100 (TBS-
T), 1% bovine serum albumin (BSA) in an incubator
shaker at 37°C, 100 rpm for 2 hours. Sections were then
washed in TBS-T with 1% BSA and incubated in 1:500
dilution of donkey anti-rabbit Alexa Fluor 568 secondary
antibody and 300 nM DAPI in TBS-T with 1% BSA for
90 minutes at room temperature on a rocking platform.
Sections were washed in TBS and mounted on slides.
Coverslips were applied with Prolong Gold anti-fade
mounting media (Invitrogen, Grand Island, NY). Images
of the immunostained sections were acquired with a
20× air objective on either a Nikon C1Si or a Nikon A1
laser scanning confocal microscope using laser lines of
405 (blue) 488 (green) 561 (red) (Tokyo, Japan). Laser
power percentage, gain, and offset settings were held
constant for all images acquired and saturation was
never reached. All images were acquired during one
continuous session to prevent effects of decay of laser
intensity.
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BACE1: β-site amyloid precursor protein cleaving enzyme 1; BSA: bovine
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protein; NCAM: neural cell adhesion molecule; OB: olfactory bulb; OE:
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standard error of the mean; TBS: tris buffered saline; TBS-T: tris buffered
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Acknowledgements
We would like to thank Rodrigo Pacifico for assistance with whole-mount
OB confocal microscopy, and members of the Vassar Lab for helpful
discussions. This study was funded through National Institutes of Health
grant 2 R01 AG022560.
Author details
1Department of Cell and Molecular Biology, Feinberg School of Medicine,
Northwestern University, Chicago, IL 60611, USA.
2Department of
Neurobiology, Northwestern University, Evanston, IL 60208, USA.
Authors’ contributions
TWR bred mice, performed whole-mount experiments, performed OB
section experiments and confocal microscopy, assembled figures, and wrote
the Methods section. WAE performed confocal microscopy and assisted in
figure preparation. TCB provided OMP-GFP, MOR23-GFP, and M72-GFP mice,
participated in the study design, trained and helped perform whole-mount
experiments, and participated in the interpretation of results. RV conceived
of the study, participated in its design and coordination, interpreted results,
and drafted the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 24 December 2011 Accepted: 28 December 2011
Published: 28 December 2011
References
1. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P,
Teplow DB, Ross S, Amarante P, Loeloff R, et al: Beta-secretase cleavage of
Alzheimer’s amyloid precursor protein by the transmembrane aspartic
protease BACE. Science 1999, 286:735-741.
2. Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, Brashler JR,
Stratman NC, Mathews WR, Buhl AE, et al: Membrane-anchored aspartyl
protease with Alzheimer’s disease beta-secretase activity. Nature 1999,
402:533-537.
3. Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, Doan M,
Dovey HF, Frigon N, Hong J, et al: Purification and cloning of amyloid
precursor protein beta-secretase from human brain. Nature 1999,
402:537-540.
4. Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, Gloger IS,
Murphy KE, Southan CD, Ryan DM, et al: Identification of a novel aspartic
protease (Asp 2) as beta-secretase. Mol Cell Neurosci 1999, 14:419-427.
5. Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J: Human aspartic
protease memapsin 2 cleaves the beta-secretase site of beta-amyloid
precursor protein. Proc Natl Acad Sci USA 2000, 97:1456-1460.
6. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, Fan W, Kha H,
Zhang J, Gong Y, et al: Mice deficient in BACE1, the Alzheimer’s beta-
secretase, have normal phenotype and abolished beta-amyloid
generation. Nat Neurosci 2001, 4:231-232.
7. Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS,
Freedman SB, Frigon NL, Games D, Hu K, et al: BACE knockout mice are
healthy despite lacking the primary beta-secretase activity in brain:
implications for Alzheimer’s disease therapeutics. Hum Mol Genet 2001,
10:1317-1324.
8. Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, Citron M,
Vassar R, Disterhoft JF: BACE1 deficiency rescues memory deficits and
cholinergic dysfunction in a mouse model of Alzheimer’s disease.
Neuron 2004, 41:27-33.
9. Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, Vassar R,
Disterhoft JF: Temporal memory deficits in Alzheimer’s mouse models:
rescue by genetic deletion of BACE1. Eur J Neurosci 2006, 23:251-260.
10. Laird FM, Cai H, Savonenko AV, Farah MH, He K, Melnikova T, Wen H,
Chiang HC, Xu G, Koliatsos VE, et al: BACE1, a major determinant of
selective vulnerability of the brain to amyloid-beta amyloidogenesis, is
essential for cognitive, emotional, and synaptic functions. J Neurosci
2005, 25:11693-11709.
11. Hitt BD, Jaramillo TC, Chetkovich DM, Vassar R: BACE1-/- mice exhibit
seizure activity that does not correlate with sodium channel level or
axonal localization. Mol Neurodegener 2010, 5:31.
12. Hu X, Zhou X, He W, Yang J, Xiong W, Wong P, Wilson CG, Yan R: BACE1
deficiency causes altered neuronal activity and neurodegeneration. J
Neurosci 2010, 30:8819-8829.
13. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A,
DeStrooper B, Saftig P, Birchmeier C, Haass C: Control of peripheral nerve
myelination by the beta-secretase BACE1. Science 2006, 314:664-666.
14. Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, Yan R: Bace1
modulates myelination in the central and peripheral nervous system.
Nat Neurosci 2006, 9:1520-1525.
15. Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH,
Pettingell WH, He P, Lee VM, Woolf CJ, Kovacs DM: BACE1 regulates
voltage-gated sodium channels and neuronal activity. Nat Cell Biol 2007,
9:755-764.
16. Gersbacher MT, Kim DY, Bhattacharyya R, Kovacs DM: Identification of
BACE1 cleavage sites in human voltage-gated sodium channel beta 2
subunit. Mol Neurodegener 2010, 5:61.
17. Vassar R, Kovacs DM, Yan R, Wong PC: The beta-secretase enzyme BACE
in health and Alzheimer’s disease: regulation, cell biology, function, and
therapeutic potential. J Neurosci 2009, 29:12787-12794.
18. Hemming ML, Elias JE, Gygi SP, Selkoe DJ: Identification of beta-secretase
(BACE1) substrates using quantitative proteomics. PLoS One 2009, 4:
e8477.
19. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O’Connor T, Logan S, Maus E,
Citron M, Berry R, et al: Beta-site amyloid precursor protein cleaving
enzyme 1 levels become elevated in neurons around amyloid plaques:
implications for Alzheimer’s disease pathogenesis. J Neurosci 2007,
27:3639-3649.
20. Yan XX, Xiong K, Luo XG, Struble RG, Clough RW: beta-Secretase
expression in normal and functionally deprived rat olfactory bulbs:
inverse correlation with oxidative metabolic activity. J Comp Neurol 2007,
501:52-69.
Rajapaksha et al. Molecular Neurodegeneration 2011, 6:88
http://www.molecularneurodegeneration.com/content/6/1/88
Page 8 of 921. Sakano H: Neural map formation in the mouse olfactory system. Neuron
2010, 67:530-542.
22. Buck L, Axel R: A novel multigene family may encode odorant receptors:
a molecular basis for odor recognition. Cell 1991, 65:175-187.
23. Ressler KJ, Sullivan SL, Buck LB: A zonal organization of odorant receptor
gene expression in the olfactory epithelium. Cell 1993, 73:597-609.
24. Vassar R, Ngai J, Axel R: Spatial segregation of odorant receptor
expression in the mammalian olfactory epithelium. Cell 1993, 74:309-318.
25. Vassar R, Chao SK, Sitcheran R, Nuñez JM, Vosshall LB, Axel R: Topographic
organization of sensory projections to the olfactory bulb. Cell 1994,
79:981-991.
26. Ressler KJ, Sullivan SL, Buck LB: Information coding in the olfactory
system: evidence for a stereotyped and highly organized epitope map
in the olfactory bulb. Cell 1994, 79:1245-1255.
27. Mombaerts P, Wang F, Dulac C, Chao SK, Nemes A, Mendelsohn M,
Edmondson J, Axel R: Visualizing an olfactory sensory map. Cell 1996,
87:675-686.
28. Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S,
Serneels L, Camacho IE, Marjaux E, Craessaerts K, et al: Phenotypic and
biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem
2005, 280:30797-30806.
29. Lin DM, Wang F, Lowe G, Gold GH, Axel R, Ngai J, Brunet L: Formation of
precise connections in the olfactory bulb occurs in the absence of
odorant-evoked neuronal activity. Neuron 2000, 26:69-80.
30. Zheng C, Feinstein P, Bozza T, Rodriguez I, Mombaerts P: Peripheral
olfactory projections are differentially affected in mice deficient in a
cyclic nucleotide-gated channel subunit. Neuron 2000, 26:81-91.
31. Wong ST, Trinh K, Hacker B, Chan GC, Lowe G, Gaggar A, Xia Z, Gold GH,
Storm DR: Disruption of the type III adenylyl cyclase gene leads to
peripheral and behavioral anosmia in transgenic mice. Neuron 2000,
27:487-497.
32. Belluscio L, Gold GH, Nemes A, Axel R: Mice deficient in G(olf) are
anosmic. Neuron 1998, 20:69-81.
33. Brunjes PC, Borror MJ: Unilateral odor deprivation: differential effects due
to time of treatment. Brain Res Bull 1983, 11:501-503.
34. Potter SM, Zheng C, Koos DS, Feinstein P, Fraser SE, Mombaerts P:
Structure and emergence of specific olfactory glomeruli in the mouse. J
Neurosci 2001, 21:9713-9723.
35. Vassalli A, Rothman A, Feinstein P, Zapotocky M, Mombaerts P: Minigenes
impart odorant receptor-specific axon guidance in the olfactory bulb.
Neuron 2002, 35:681-696.
36. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC:
BACE1 is the major beta-secretase for generation of Abeta peptides by
neurons. Nat Neurosci 2001, 4:233-234.
doi:10.1186/1750-1326-6-88
Cite this article as: Rajapaksha et al.: The Alzheimer’s b-secretase
enzyme BACE1 is required for accurate axon guidance of olfactory
sensory neurons and normal glomerulus formation in the olfactory
bulb. Molecular Neurodegeneration 2011 6:88.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Rajapaksha et al. Molecular Neurodegeneration 2011, 6:88
http://www.molecularneurodegeneration.com/content/6/1/88
Page 9 of 9